Search for the latest oncology news by tumour type
ESMO 2021: NORSE Study
Highlights on erdafitinib in advanced urothelial cancer with FGFRa alterations: The NORSE study
Browsing: Tumour Stream
ESMO 2021: EORTC-1508 Study
Highlights on aspirin use in recurrent platinum-resistent ovarian cancer: EORTC-1508 study
ESMO 2021: FRAME Trial
Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer…
ESMO 2021: CheckMate 651 study
Highlights on nivolumab plus ipilimumab vs EXTREME in 1st-line high-risk squamous cell carcinoma of the…
ESMO 2021: PRODIGE 24 Trial
Highlights on gemcitabine vs mFOLFIRINOX in resected pancreatic cancer: PRODIGE 24/CCTG PA6
ESMO 2021: KRYSTAL-1 Study
Highlights on adagrasib in patients with KRASG12C-mutated colorectal cancer: The KRYSTAL-1 study
ESMO 2021: STAMPEDE Prostate Cancer Trial
Highlights on MFS analysis from combined treatments in high-risk advanced prostate cancer
ESMO 2021: HER2-targeting antibody-drug improves progression-free survival for women with deadly form of advanced breast cancer
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, has found…
ESMO 2021: Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients…
ESMO 2021: New combination of old drugs improves survival in patients with prostate cancer
A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according…